+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Mycoplasma Pneumonia Test kits Market - Global Forecast 2025-2030- Product Image
Mycoplasma Pneumonia Test kits Market - Global Forecast 2025-2030- Product Image
Sale

Mycoplasma Pneumonia Test kits Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 186 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6134496
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The mycoplasma pneumonia test kits market is evolving rapidly, shaped by cutting-edge molecular technologies and shifting diagnostic needs in global healthcare settings. Senior executives and decision-makers must navigate an increasingly complex landscape as testing platforms advance and regulatory environments fluctuate.

Market Snapshot: Mycoplasma Pneumonia Test Kits

The mycoplasma pneumonia test kits market is positioned at a pivotal stage, marked by technological progress and changing requirements among healthcare providers worldwide. Rising demand for sophisticated diagnostics, driven by both clinical expectations and an expanding spectrum of use cases, is redefining market growth and regional adoption. Recent innovations, including point-of-care solutions and data integration tools, have heightened competition while addressing previously unmet clinical needs. Market players are responding to heightened pressures by strengthening supply chains and adapting to ongoing regulatory shifts, ensuring resilience and competitive differentiation.

Scope & Segmentation

This report offers a detailed analysis of the mycoplasma pneumonia test kits market, dividing it across distinct segments to support effective strategy formation and decision-making.

  • Product Types: Culture-based test kits (A7 agar, SP4 broth), molecular test kits (conventional PCR, isothermal amplification, real time PCR), point-of-care test kits (lateral flow assays, microfluidic tests), and serological test kits (IgA, IgG, IgM).
  • Sample Types: Blood samples (plasma, serum, whole blood) and respiratory specimens (nasopharyngeal swab, sputum, throat swab).
  • End Users: Academic and research institutes, diagnostic laboratories, hospitals.
  • Distribution Channels: Direct sales, distributors, online sales, retail sales.
  • Technology Platforms: ELISA, LAMP, PCR.
  • Regional Coverage: Americas (including select US states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including major countries such as UK, Germany, France, and others), and Asia-Pacific (China, India, Japan, Australia, etc.).
  • Key Companies: Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Abbott Laboratories, bioMérieux SA, Hologic Inc., Becton, Dickinson and Company, QIAGEN N.V., Luminex Corporation, Quidel Corporation, Meridian Bioscience Inc.

Key Takeaways for Decision-Makers

  • Molecular diagnostics, particularly real time PCR and isothermal amplification, are enabling faster, more precise detection, allowing for rapid clinical decision-making and improved patient management.
  • Integration of digital health tools and cloud-based analytics is creating a more connected diagnostic infrastructure, supporting real-time surveillance and responsive public health interventions, especially useful during outbreaks.
  • Market adoption is influenced by both sample type preference and end user diversity, with blood and respiratory specimens posing distinct challenges and opportunities for workflow optimization.
  • Partnerships and joint ventures are strengthening local manufacturing capabilities, helping companies mitigate supply chain risks and address tariff-related cost pressures.
  • Diverse regional healthcare systems and regulatory requirements demand tailored market entry and expansion strategies, with collaborative approaches often necessary for effective positioning.

Tariff Impact on Supply Chains

The introduction of new US tariffs in 2025 has altered global supply chain economics for mycoplasma pneumonia test kits. Increased duties on essential raw materials and reagents have compelled manufacturers to reconsider sourcing strategies, with many opting to localize production or diversify procurement. The impact has extended downstream to pricing for laboratories and hospitals, intensifying the need for cost-efficient solutions while sparking competitive shifts in both pricing and supply reliability. These changes are prompting market participants to rethink their regional strategies for sustained growth.

Methodology & Data Sources

The research methodology underpinning this market analysis combines extensive secondary research, direct interviews with industry experts, and data triangulation. Secondary data mapping draws on scientific publications, regulatory records, and industry disclosures, while inputs from laboratory directors and R&D leaders deliver operational perspectives. Quantitative insights are supported by statistical modeling and scenario planning, ensuring robust, validated conclusions for market assessment and strategy development.

Why This Report Matters

  • Equips industry leaders with actionable intelligence to optimize product development and portfolio positioning across evolving diagnostic trends and technologies.
  • Provides deep visibility into supply chain dynamics, market segmentation, and tariff-driven strategic shifts for informed sourcing and investment decisions.
  • Supports targeted market entry and expansion with insight into regional adoption patterns and high-impact distribution strategies.

Conclusion

Rapid advances in diagnostic technology and evolving regulatory environments are transforming the mycoplasma pneumonia test kits market. By leveraging strategic insights and adapting to ongoing shifts, stakeholders are better positioned to achieve resilient growth and sustained market relevance.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of point-of-care molecular isothermal amplification assays for rapid mycoplasma pneumonia detection in outpatient settings
5.2. Development of multiplex respiratory panels incorporating Mycoplasma pneumoniae and other atypical pathogens for comprehensive diagnosis
5.3. Rising demand for fully automated high-throughput mycoplasma pneumonia test platforms in reference laboratories
5.4. Impact of near-patient digital PCR methods on turnaround times and sensitivity in pediatric mycoplasma pneumonia cases
5.5. Influence of growing antibiotic resistance surveillance on the design of mycoplasma pneumonia testing protocols across healthcare networks
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Mycoplasma Pneumonia Test kits Market, by Product Type
8.1. Introduction
8.2. Culture Based Test Kits
8.2.1. A7 Agar
8.2.2. SP4 Broth
8.3. Molecular Test Kits
8.3.1. Conventional PCR
8.3.2. Isothermal Amplification
8.3.3. Real Time PCR
8.4. Point Of Care Test Kits
8.4.1. Lateral Flow Assays
8.4.2. Microfluidic Tests
8.5. Serological Test Kits
8.5.1. Iga
8.5.2. Igg
8.5.3. Igm
9. Mycoplasma Pneumonia Test kits Market, by Sample Type
9.1. Introduction
9.2. Blood Samples
9.2.1. Plasma
9.2.2. Serum
9.2.3. Whole Blood
9.3. Respiratory Specimens
9.3.1. Nasopharyngeal Swab
9.3.2. Sputum
9.3.3. Throat Swab
10. Mycoplasma Pneumonia Test kits Market, by End User
10.1. Introduction
10.2. Academic & Research Institutes
10.3. Diagnostic Laboratories
10.4. Hospitals
11. Mycoplasma Pneumonia Test kits Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Distributors
11.4. Online Sales
11.5. Retail Sales
12. Mycoplasma Pneumonia Test kits Market, by Technology
12.1. Introduction
12.2. ELISA
12.3. LAMP
12.4. PCR
13. Americas Mycoplasma Pneumonia Test kits Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Mycoplasma Pneumonia Test kits Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Mycoplasma Pneumonia Test kits Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific Inc.
16.3.2. F. Hoffmann-La Roche Ltd.
16.3.3. Abbott Laboratories
16.3.4. bioMérieux SA
16.3.5. Hologic, Inc.
16.3.6. Becton, Dickinson and Company
16.3.7. QIAGEN N.V.
16.3.8. Luminex Corporation
16.3.9. Quidel Corporation
16.3.10. Meridian Bioscience, Inc.
17. ResearchAI18. ResearchStatistics19. ResearchContacts20. ResearchArticles21. Appendix
List of Figures
FIGURE 1. MYCOPLASMA PNEUMONIA TEST KITS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. MYCOPLASMA PNEUMONIA TEST KITS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. MYCOPLASMA PNEUMONIA TEST KITS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. MYCOPLASMA PNEUMONIA TEST KITS MARKET: RESEARCHAI
FIGURE 26. MYCOPLASMA PNEUMONIA TEST KITS MARKET: RESEARCHSTATISTICS
FIGURE 27. MYCOPLASMA PNEUMONIA TEST KITS MARKET: RESEARCHCONTACTS
FIGURE 28. MYCOPLASMA PNEUMONIA TEST KITS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. MYCOPLASMA PNEUMONIA TEST KITS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY CULTURE BASED TEST KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY CULTURE BASED TEST KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY A7 AGAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY A7 AGAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SP4 BROTH, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SP4 BROTH, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY CULTURE BASED TEST KITS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY CULTURE BASED TEST KITS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY MOLECULAR TEST KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY MOLECULAR TEST KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY CONVENTIONAL PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY CONVENTIONAL PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY REAL TIME PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY REAL TIME PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY MOLECULAR TEST KITS, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY MOLECULAR TEST KITS, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY POINT OF CARE TEST KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY POINT OF CARE TEST KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY LATERAL FLOW ASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY LATERAL FLOW ASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY MICROFLUIDIC TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY MICROFLUIDIC TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY POINT OF CARE TEST KITS, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY POINT OF CARE TEST KITS, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SEROLOGICAL TEST KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SEROLOGICAL TEST KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY IGA, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY IGA, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY IGG, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY IGG, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY IGM, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY IGM, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SEROLOGICAL TEST KITS, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SEROLOGICAL TEST KITS, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY BLOOD SAMPLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY BLOOD SAMPLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY PLASMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY PLASMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SERUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SERUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY BLOOD SAMPLES, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY BLOOD SAMPLES, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY RESPIRATORY SPECIMENS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY RESPIRATORY SPECIMENS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY NASOPHARYNGEAL SWAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY NASOPHARYNGEAL SWAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SPUTUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SPUTUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY THROAT SWAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY THROAT SWAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY RESPIRATORY SPECIMENS, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY RESPIRATORY SPECIMENS, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY RETAIL SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY RETAIL SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY LAMP, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY LAMP, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY CULTURE BASED TEST KITS, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY CULTURE BASED TEST KITS, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY MOLECULAR TEST KITS, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY MOLECULAR TEST KITS, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY POINT OF CARE TEST KITS, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY POINT OF CARE TEST KITS, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SEROLOGICAL TEST KITS, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SEROLOGICAL TEST KITS, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY BLOOD SAMPLES, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY BLOOD SAMPLES, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY RESPIRATORY SPECIMENS, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY RESPIRATORY SPECIMENS, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY CULTURE BASED TEST KITS, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY CULTURE BASED TEST KITS, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY MOLECULAR TEST KITS, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY MOLECULAR TEST KITS, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY POINT OF CARE TEST KITS, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY POINT OF CARE TEST KITS, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SEROLOGICAL TEST KITS, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SEROLOGICAL TEST KITS, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY BLOOD SAMPLES, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY BLOOD SAMPLES, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY RESPIRATORY SPECIMENS, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY RESPIRATORY SPECIMENS, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 143. CANADA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 144. CANADA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 145. CANADA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY CULTURE BASED TEST KITS, 2018-2024 (USD MILLION)
TABLE 146. CANADA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY CULTURE BASED TEST KITS, 2025-2030 (USD MILLION)
TABLE 147. CANADA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY MOLECULAR TEST KITS, 2018-2024 (USD MILLION)
TABLE 148. CANADA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY MOLECULAR TEST KITS, 2025-2030 (USD MILLION)
TABLE 149. CANADA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY POINT OF CARE TEST KITS, 2018-2024 (USD MILLION)
TABLE 150. CANADA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY POINT OF CARE TEST KITS, 2025-2030 (USD MILLION)
TABLE 151. CANADA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SEROLOGICAL TEST KITS, 2018-2024 (USD MILLION)
TABLE 152. CANADA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SEROLOGICAL TEST KITS, 2025-2030 (USD MILLION)
TABLE 153. CANADA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 154. CANADA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 155. CANADA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY BLOOD SAMPLES, 2018-2024 (USD MILLION)
TABLE 156. CANADA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY BLOOD SAMPLES, 2025-2030 (USD MILLION)
TABLE 157. CANADA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY RESPIRATORY SPECIMENS, 2018-2024 (USD MILLION)
TABLE 158. CANADA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY RESPIRATORY SPECIMENS, 2025-2030 (USD MILLION)
TABLE 159. CANADA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. CANADA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. CANADA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. CANADA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. CANADA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 164. CANADA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 165. MEXICO MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 166. MEXICO MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 167. MEXICO MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY CULTURE BASED TEST KITS, 2018-2024 (USD MILLION)
TABLE 168. MEXICO MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY CULTURE BASED TEST KITS, 2025-2030 (USD MILLION)
TABLE 169. MEXICO MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY MOLECULAR TEST KITS, 2018-2024 (USD MILLION)
TABLE 170. MEXICO MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY MOLECULAR TEST KITS, 2025-2030 (USD MILLION)
TABLE 171. MEXICO MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY POINT OF CARE TEST KITS, 2018-2024 (USD MILLION)
TABLE 172. MEXICO MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY POINT OF CARE TEST KITS, 2025-2030 (USD MILLION)
TABLE 173. MEXICO MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SEROLOGICAL TEST KITS, 2018-2024 (USD MILLION)
TABLE 174. MEXICO MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SEROLOGICAL TEST KITS, 2025-2030 (USD MILLION)
TABLE 175. MEXICO MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 176. MEXICO MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 177. MEXICO MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY BLOOD SAMPLES, 2018-2024 (USD MILLION)
TABLE 178. MEXICO MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY BLOOD SAMPLES, 2025-2030 (USD MILLION)
TABLE 179. MEXICO MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY RESPIRATORY SPECIMENS, 2018-2024 (USD MILLION)
TABLE 180. MEXICO MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY RESPIRATORY SPECIMENS, 2025-2030 (USD MILLION)
TABLE 181. MEXICO MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. MEXICO MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. MEXICO MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. MEXICO MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. MEXICO MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 186. MEXICO MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY CULTURE BASED TEST KITS, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY CULTURE BASED TEST KITS, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY MOLECULAR TEST KITS, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY MOLECULAR TEST KITS, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY POINT OF CARE TEST KITS, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY POINT OF CARE TEST KITS, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SEROLOGICAL TEST KITS, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SEROLOGICAL TEST KITS, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY BLOOD SAMPLES, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY BLOOD SAMPLES, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY RESPIRATORY SPECIMENS, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY RESPIRATORY SPECIMENS, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY CULTURE BASED TEST KITS, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY CULTURE BASED TEST KITS, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY MOLECULAR TEST KITS, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY MOLECULAR TEST KITS, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY POINT OF CARE TEST KITS, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY POINT OF CARE TEST KITS, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SEROLOGICAL TEST KITS, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SEROLOGICAL TEST KITS, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY BLOOD SAMPLES, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY BLOOD SAMPLES, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY RESPIRATORY SPECIMENS, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY RESPIRATORY SPECIMENS, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY CULTURE BASED TEST KITS, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY CULTURE BASED TEST KITS, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY MOLECULAR TEST KITS, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY MOLECULAR TEST KITS, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY POINT OF CARE TEST KITS, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY POINT OF CARE TEST KITS, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SEROLOGICAL TEST KITS, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SEROLOGICAL TEST KITS, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY BLOOD SAMPLES, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY BLOOD SAMPLES, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY RESPIRATORY SPECIMENS, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY RESPIRATORY SPECIMENS, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY CULTURE BASED TEST KITS, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY CULTURE BASED TEST KITS, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY MOLECULAR TEST KITS, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY MOLECULAR TEST KITS, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY POINT OF CARE TEST KITS, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY POINT OF CARE TEST KITS, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SEROLOGICAL TEST KITS, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SEROLOGICAL TEST KITS, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY BLOOD SAMPLES, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY BLOOD SAMPLES, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY RESPIRATORY SPECIMENS, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY RESPIRATORY SPECIMENS, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 277. GERMANY MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 278. GERMANY MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 279. GERMANY MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY CULTURE BASED TEST KITS, 2018-2024 (USD MILLION)
TABLE 280. GERMANY MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY CULTURE BASED TEST KITS, 2025-2030 (USD MILLION)
TABLE 281. GERMANY MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY MOLECULAR TEST KITS, 2018-2024 (USD MILLION)
TABLE 282. GERMANY MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY MOLECULAR TEST KITS, 2025-2030 (USD MILLION)
TABLE 283. GERMANY MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY POINT OF CARE TEST KITS, 2018-2024 (USD MILLION)
TABLE 284. GERMANY MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY POINT OF CARE TEST KITS, 2025-2030 (USD MILLION)
TABLE 285. GERMANY MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SEROLOGICAL TEST KITS, 2018-2024 (USD MILLION)
TABLE 286. GERMANY MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SEROLOGICAL TEST KITS, 2025-2030 (USD MILLION)
TABLE 287. GERMANY MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 288. GERMANY MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 289. GERMANY MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY BLOOD SAMPLES, 2018-2024 (USD MILLION)
TABLE 290. GERMANY MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY BLOOD SAMPLES, 2025-2030 (USD MILLION)
TABLE 291. GERMANY MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY RESPIRATORY SPECIMENS, 2018-2024 (USD MILLION)
TABLE 292. GERMANY MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY RESPIRATORY SPECIMENS, 2025-2030 (USD MILLION)
TABLE 293. GERMANY MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. GERMANY MYCOPLASMA PNEUMONIA TEST KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. GERMANY

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Mycoplasma Pneumonia Test kits Market report include:
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • bioMérieux SA
  • Hologic, Inc.
  • Becton, Dickinson and Company
  • QIAGEN N.V.
  • Luminex Corporation
  • Quidel Corporation
  • Meridian Bioscience, Inc.

Related Topics

Related Reports

Mycoplasma Pneumonia IgM Antibody Test Kits Market - Global Forecast 2025-2030 - Product Image

Mycoplasma Pneumonia IgM Antibody Test Kits Market - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Pneumonia Diagnostics Kit Market - Global Forecast 2025-2030 - Product Image

Pneumonia Diagnostics Kit Market - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Bacterial Pneumonia Global Market Report 2025 - Product Image

Bacterial Pneumonia Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Pneumonia Testing - Global Strategic Business Report - Product Image

Pneumonia Testing - Global Strategic Business Report

  • Report
  • 259 Pages
  • Global
From
Bacterial Pneumonia Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Bacterial Pneumonia Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 188 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.